1282 completed, 296 unknown, 139 terminated, 115 recruiting. 457 Phase 2, 438 Phase 3, 435 Phase 4, 423 Phase 1, 255 Not applicable.
Follow Metformin: new trials by email Literature Review of Metformin trials Research Report on Metformin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations Metformin - Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Not yet recruiting | Duke University | 45 | 2027-02-01 | 2026-11-03 |
| Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis Metformin - Psychosis, Cannabis Use | Phase 4 | Not yet recruiting | Nova Scotia Health Authority | 24 | 2027-02-01 | 2026-11-10 |
| Canagliflozin Plus Progestin for Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer LNG-IUS: levonorgestrel intrauterine system, Metformin, Canagliflozin - Endometrioid Endometrial Cancer, Atypical Endometrial Hyperplasia | Phase 2 | Not yet recruiting | Wang Yingmei | 102 | 2027-01-01 | 2026-10-22 |
| Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients Metformin, Val, Cel and Met XR Low, Val, Cel and Met XR High - Type 2 Diabetes, High Blood Pressure | Phase 1 / Phase 2 | Withdrawn | ARKAY Therapeutics | 2026-12-10 | 2026-07-16 | |
| Sotagliflozin Versus Empagliflozin Added to Metformin for Glycemic Control in Type 2 Diabetes Sotagliflozin, Empagliflozin (oral), Metformin - Type 2 Diabetes Mellitus (DM) | Phase 4 | Not yet recruiting | Allied Hospital Faisalabad | 140 | 2026-12-01 | 2026-11-16 |
| Henagliflozin on Myocardial Fibrosis in Obese Patients Henagliflozin 10 mg, Metformin - Myocardial Fibrosis, Obesity | Not applicable | Not yet recruiting | Jing Ma | 100 | 2026-12-01 | 2026-11-19 |
| Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Therapy Fuling Yunhua Granules, Dihuang Baoyuan Granules, Fuling Yunhua Granules Matched Placebo - Diabetes Mellitus, Type 2 | Phase 2 | Not yet recruiting | Beijing Supreme Life Pharmaceutical Technology Co., Ltd. | 150 | 2026-11-20 | 2026-11-10 |
| An Evaluation of the Potential for VH4011499 Drug-drug-interactions VH4011499, Ritonavir, Efavirenz - HIV Infections | Phase 1 | Not yet recruiting | ViiV Healthcare | 75 | 2026-11-16 | 2026-11-16 |
| Metformin and ACLR Muscle Recovery Metformin, Placebo - Atrophy, Inflammation | Early Phase 1 | Not yet recruiting | University of Utah | 40 | 2026-11-01 | 2026-07-13 |
| DDI Study of ECC0509 With Metformin, Midazolam, and Caffeine ECC0509, Metformin, Caffeine - Steatohepatitis, Nonalcoholic, Osteo Arthritis | Phase 1 | Not yet recruiting | Eccogene | 40 | 2026-11-01 | 2026-10-14 |
| Efficacy of Topical Metformin 30% Versus Minoxidil 5% in the Treatment of Alopecia Areata : Comparative Study Metformin 30% Topical Lotion, Minoxidil 5 % Topical Spray - Alopecia Areata(AA) | Not applicable | Recruiting | Sohag University | 60 | 2026-10-29 | 2026-11-19 |
| Microneedling-Assisted Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma Metformin 30% Topical Lotion, Tranexamic Acid 0.5% Topical Solution, Modified Kligman's Formula - Melasma (Facial Melasma) | Phase 4 | Enrolling by invitation | Sameh Sarsik | 80 | 2026-10-25 | 2026-10-27 |
| Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks Topical anti-aging peptide serum - Aging | Early Phase 1 | Enrolling by invitation | Frontiers in Bioscience Research Institute and Aging | 48 | 2026-10-21 | 2026-10-22 |
| Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia Metformin, Naproxen Sodium - Fanconi Anemia, Head and Neck Cancer | Phase 1 | Recruiting | Rockefeller University | 80 | 2026-10-14 | 2026-10-28 |
| Cardioprotective Effect of Empagliflozin in Breast Cancer Patients Empagliflozin (EMPA), Metformin - Empgliflozin Cardioprotective Effect | Phase 3 | Not yet recruiting | Tanta University | 150 | 2026-10-01 | 2026-09-24 |
| Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD Metformin + Dapagliflozin, Metformin - Type 2 Diabetes, Metabolic Dysfunction-Associated Steatotic Liver Disease | Not applicable | Not yet recruiting | The 95th Hospital of Putian,Putian, Fujian, China | 84 | 2026-10-01 | 2026-08-21 |
| Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis Metformin, Matching Placebo - Idiopathic Pulmonary Fibrosis | Phase 3 | Not yet recruiting | University of Massachusetts, Worcester | 800 | 2026-09-28 | 2026-09-08 |
| Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects VC005 and verapamil, VC005 and probenecid, VC005 and metformin - Healthy Adult Participants | Phase 1 | Not yet recruiting | Jiangsu vcare pharmaceutical technology co., LTD | 84 | 2026-09-20 | 2026-09-01 |
| Efficacy of Vildagliptin Versus Metformin in Patients With Polycystic Ovary Syndrome Metformin, Vildagliptin (Galvus) - Poly Cystic Ovary Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 70 | 2026-09-20 | 2026-09-21 |
| A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy Adults Itraconazole, Rifampicin, Omeprazole - Healthy Subjects | Phase 1 | Not yet recruiting | InventisBio Co., Ltd | 60 | 2026-09-16 | 2026-10-15 |
Showing 20 of 2015. Sign in to see all of them.
Diabetes Mellitus, Type 2 (709) · Diabetes Mellitus (227) · Polycystic Ovary Syndrome (161) · Insulin Resistance (152) · Obesity (111) · Prediabetic State (48) · Diabetes, Gestational (46) · Metabolic Syndrome (46) · Breast Neoplasms (40) · Dyslipidemias (31) · Glucose Intolerance (31) · Prostatic Neoplasms (31) · Hyperglycemia (29) · Non-alcoholic Fatty Liver Disease (29) · Glucose Metabolism Disorders (25)
Merck Sharp & Dohme LLC (69) · AstraZeneca (58) · Sanofi (56) · Novo Nordisk A/S (49) · Boehringer Ingelheim (48) · Takeda (25) · GlaxoSmithKline (23) · Eli Lilly and Company (21) · Novartis Pharmaceuticals (19) · Ain Shams University (17) · Janssen Research & Development, LLC (17) · Assiut University (15) · M.D. Anderson Cancer Center (15) · University of California, San Francisco (15) · Cairo University (13)
United States (612) · China (215) · Canada (149) · Germany (139) · Mexico (134) · South Korea (130) · Egypt (124) · Italy (98) · India (88) · United Kingdom (87) · France (81) · Russia (81) · Poland (77) · Spain (77) · Brazil (60)
Stefano Palomba, MD (10) · James D. Carlson,, Pharm.D, (7) · James D Carlson, Pharm. D. (6)
PMID 32501595, PMID 38837240, PMID 25504028, PMID 27402391, PMID 38770818, PMID 23010561, PMID 26580237, PMID 26691396, PMID 26894924, PMID 27033025, PMID 27161178, PMID 27977934, PMID 31606880, PMID 31797522, PMID 32324065, PMID 32324082, PMID 32372382, PMID 32648108, PMID 32994091, PMID 34213819, PMID 37435938, PMID 39963952, PMID 21883806, PMID 22193143, PMID 22862847, PMID 23186975, PMID 23795975, PMID 24517339, PMID 26579834, PMID 27600862, PMID 29974618, PMID 42653697, PMID 19245711, PMID 19491536, PMID 19878259, PMID 21450987, PMID 21680990, PMID 22055210, PMID 24561125, PMID 24742013, PMID 24786834, PMID 24918789, PMID 25329038, PMID 25813214, PMID 26121561, PMID 26373629, PMID 27461213, PMID 28197834, PMID 28241822, PMID 28327140
2008 (13), 2015 (13), 2016 (12), 2014 (11), 2019 (8), 2009 (7), 2023 (7), 2018 (6), 2017 (5), 2005 (4), 2004 (3), P30CA023074 (3), P30CA060553 (3), 2025 (2), N01MH090001 (2)